45
Theravie Pharma raises $2.25M in first Regulation D offering from San Diego biotech
Company raise · Raising · SAN DIEGO, CA · Form D filed 2026-10-19
Theravie Pharma, a Delaware biotech corporation incorporated in 2025, is raising $2.25M under Regulation D exemption 6(b). The company has sold $750K to one investor so far and is seeking an additional $1.5M.
Note: Company incorporated in 2025 and filed first Form D in October 2026; very early stage with only one investor to date.
First raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Samia Lina Helena Almoughrabie | Executive Officer, Director |
| Richard Louis Gallo | Executive Officer, Director |
Signed by Samia Lina Helena Almoughrabie, President of the Issuer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.